Beyond the Guidelines: Perspectives on the Role of PARP
Inhibition in the Management of Ovarian Cancer — Interview with Dr
Moore on the following topics:
Genomic testing for patients with newly diagnosed ovarian
cancer (OC) (00:00)
Management of OC with germline BRCA mutation after surgical
debulking; role of bevacizumab and PARP inhibitors (3:40)
Therapeutic approach for patients with homologous
recombination-proficient OC (8:20)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.